Quanterix Co. (NASDAQ:QTRX) Short Interest Update

Quanterix Co. (NASDAQ:QTRX) was the target of a significant growth in short interest in February. As of February 15th, there was short interest totalling 2,770,000 shares, a growth of 21.5% from the January 31st total of 2,280,000 shares. Currently, 8.4% of the shares of the stock are short sold. Based on an average trading volume of 633,300 shares, the short-interest ratio is currently 4.4 days.

Quanterix Trading Down 2.2 %

Shares of NASDAQ:QTRX traded down $0.17 during midday trading on Thursday, reaching $7.48. 303,956 shares of the company were exchanged, compared to its average volume of 479,216. The business’s fifty day moving average is $9.11 and its two-hundred day moving average is $11.32. Quanterix has a one year low of $6.80 and a one year high of $29.70. The stock has a market cap of $288.16 million, a PE ratio of -7.06 and a beta of 1.33.

Quanterix (NASDAQ:QTRX) last posted its earnings results on Monday, December 23rd. The company reported ($0.22) EPS for the quarter. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. As a group, sell-side analysts expect that Quanterix will post -0.98 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, TD Cowen increased their target price on Quanterix from $13.50 to $16.00 and gave the stock a “hold” rating in a research report on Wednesday, November 13th.

Institutional Investors Weigh In On Quanterix

Several institutional investors have recently modified their holdings of the stock. Bank of New York Mellon Corp raised its holdings in Quanterix by 1.8% during the 4th quarter. Bank of New York Mellon Corp now owns 108,186 shares of the company’s stock valued at $1,150,000 after buying an additional 1,963 shares during the period. Tower Research Capital LLC TRC raised its stake in shares of Quanterix by 219.1% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,702 shares of the company’s stock valued at $61,000 after acquiring an additional 3,915 shares during the period. Hsbc Holdings PLC lifted its holdings in shares of Quanterix by 25.8% in the 4th quarter. Hsbc Holdings PLC now owns 19,371 shares of the company’s stock worth $205,000 after acquiring an additional 3,974 shares during the last quarter. Canada Pension Plan Investment Board boosted its stake in shares of Quanterix by 64.5% during the 4th quarter. Canada Pension Plan Investment Board now owns 10,200 shares of the company’s stock worth $108,000 after purchasing an additional 4,000 shares during the period. Finally, MetLife Investment Management LLC grew its holdings in Quanterix by 21.9% during the 4th quarter. MetLife Investment Management LLC now owns 23,983 shares of the company’s stock valued at $255,000 after purchasing an additional 4,303 shares during the last quarter. 86.48% of the stock is owned by institutional investors.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.